FEMCHECK
LIVE

Serial Number

79299178

Owner

SCIENCE HAVEN LIMITED

Attorney

Kazuyo Morita

Filing Date

May 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

FEMCHECK Trademark

Serial Number: 79299178 • Registration: 6541669

FEMCHECK is a trademark filed by SCIENCE HAVEN LIMITED on May 26, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SCIENCE HAVEN LIMITED

Creative Diagnostic Research Laboratory Massey University, Drysdale Drive
Palmerston North 4474 , NZ

Entity Type: 99

Trademark Details

Filing Date

May 26, 2020

Registration Date

November 2, 2021

Published for Opposition

August 17, 2021

Goods & Services

Downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; Downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females

Non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females

Retail and wholesale store services for non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; online advertising and marketing services in relation to the aforementioned goods

Software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; software as a service (SAAS) services featuring software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 22, 2022 FICS
FINAL DISPOSITION PROCESSED
Apr 22, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 2, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 2, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 15, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 28, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 28, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 13, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 13, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 13, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 13, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 13, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2021 TROA
ATTORNEY REVIEW COMPLETED
Mar 23, 2021 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Mar 23, 2021 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Feb 28, 2021 LIMG
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2021 NREP
REFUSAL PROCESSED BY IB
Jan 11, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 8, 2020 RFCR
APPLICATION FILING RECEIPT MAILED
Dec 8, 2020 MAFR
NON-FINAL ACTION WRITTEN
Dec 7, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 3, 2020 REPR